Current and future applications of GnRH, kisspeptin and neurokinin B analogues

Nature Reviews Endocrinology

Volumn 9, Issue 8, 2013, Pages 451-466

  Millar, Robert P ^a   Newton, Claire L ^b  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; ASPARTIC ACID; FOLLITROPIN; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 54; GONADORELIN; GONADORELIN ANTAGONIST; GONADORELIN DERIVATIVE; KISSPEPTIN; LUTEINIZING HORMONE; NEUROKININ B DERIVATIVE; PHENYLALANINE; TYROSINE;

AMINO TERMINAL SEQUENCE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELL SURFACE; CRYSTAL STRUCTURE; DESENSITIZATION; EXPERIMENTAL DIABETES MELLITUS; HORMONAL REGULATION; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; INFERTILITY THERAPY; MEDIAN EMINENCE; NEGATIVE FEEDBACK; NEUROENDOCRINE SYSTEM; NONHUMAN; PHARMACOPHORE; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; STEROID RELEASE;

ANIMALS; GONADOTROPIN-RELEASING HORMONE; HUMANS; KISSPEPTINS; NEUROKININ B;

EID: 84880923082     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2013.120     Document Type: Review

References (170)

1. Fink, G. in The Physiology of Reproduction (eds Knobil, E. & Neill, J.) 1349-1377 (Raven Press, New York, 1988)
2. Seeburg, P. H., Mason, A. J., Stewart, T. A. & Nikolics, K. The mammalian GnRH gene and its pivotal role in reproduction. Recent Prog. Horm. Res 43, 69-98 (1987)
3. Millar, R. P. et al. Gonadotropin-releasing hormone receptors. Endocr. Rev. 25, 235-275 (2004)
4. Millar, R. P. GnRHs and GnRH receptors. Anim. Reprod. Sci. 88, 5-28 (2005)
5. Navarro, V. M. & Tena-Sempere, M. Neuroendocrine control by kisspeptins: role in metabolic regulation of fertility. Nat. Rev. Endocrinol. 8, 40-53 (2011)
6. de Roux, N. et al. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc. Natl Acad. Sci. USA 100, 10972-10976 (2003)
7. Seminara, S. B. et al. The GPR54 gene as a regulator of puberty. N. Engl. J. Med. 349, 1614-1627 (2003)
8. Topaloglu, A. K. et al. Inactivating KISS1 mutation and hypogonadotropic hypogonadism. N. Engl. J. Med. 366, 629-635 (2012)
9. Topaloglu, A. K. et al. TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for neurokinin B in the central control of reproduction. Nat. Genet. 41, 354-358 (2009)
10. Gianetti, E. et al. TAC3/TACR3 mutations reveal preferential activation of gonadotropin-releasing hormone release by neurokinin B in neonatal life followed by reversal in adulthood. J. Clin. Endocrinol. Metab. 95, 2857-2867 (2010)
11. Young, J. et al. TAC3 and TACR3 defects cause hypothalamic congenital hypogonadotropic hypogonadism in humans. J. Clin. Endocrinol. Metab. 95, 2287-2295 (2010)
12. Terasawa, E. & Fernandez, D. L. Neurobiological mechanisms of the onset of puberty in primates. Endocr. Rev. 22, 111-151 (2001)
13. Roa, J. & Herbison, A. E. Direct regulation of GnRH neuron excitability by arcuate nucleus POMC and NPY neuron neuropeptides in female mice. Endocrinology 153, 5587-5599 (2012)
14. Matsuo, H., Baba, Y., Nair, R. M., Arimura, A. & Schally, A. V. Structure of the porcine LH-and FSH-releasing hormone. I. The proposed amino acid sequence. Biochem. Biophys. Res. Commun. 43, 1334-1339 (1971)
15. Baba, Y., Matsuo, H. & Schally, A. V. Structure of the porcine LH-and FSH-releasing hormone. II. Confirmation of the proposed structure by conventional sequential analyses. Biochem. Biophys. Res. Commun. 44, 459-463 (1971)
16. Schally, A. V. et al. Isolation and properties of the FSH and LH-releasing hormone. Biochem. Biophys. Res. Commun. 43, 393-399 (1971)
17. King, J. A. & Millar, R. P. Heterogeneity of vertebrate luteinizing hormone-releasing hormone. Science 206, 67-69 (1979)
18. King, J. A. & Millar, R. P. Structure of chicken hypothalamic luteinizing hormone-releasing hormone. II. Isolation and characterization. J. Biol. Chem. 257, 10729-10732 (1982)
19. King, J. A. & Millar, R. P. Structure of chicken hypothalamic luteinizing hormone-releasing hormone. I. Structural determination on partially purified material. J. Biol. Chem. 257, 10722-10728 (1982)
20. Adams, B. A. et al. Six novel gonadotropin-releasing hormones are encoded as triplets on each of two genes in the protochordate, Ciona intestinalis. Endocrinology 144, 1907-1919 (2003)
21. Jimenez-Liñan, M., Rubin, B. S. & King, J. C. Examination of guinea pig luteinizing hormone-releasing hormone gene reveals a unique decapeptide and existence of two transcripts in the brain. Endocrinology 138, 4123-4130 (1997)
22. King, J. A. & Millar, R. P. Evolution of gonadotropin-releasing hormones. Trends Endocrinol. Metab. 3, 339-346 (1992)
23. King, J. A. & Millar, R. P. Evolutionary aspects of gonadotropin-releasing hormone and its receptor. Cell. Mol. Neurobiol. 15, 5-23 (1995)
24. King, J. A. & Millar, R. P. in GnRH Neurons: Gene to Behavior (eds Parhar, I. S. & Sakuma, Y.) 51-77 (Brain Shuppan, Tokyo, 1997)
25. Millar, R. P., King, J. A., Davidson, J. S. & Milton, R. C. Gonadotrophin-releasing hormone-diversity of functions and clinical applications. S. Afr. Med. J. 72, 748-755 (1987)
26. Millar, R. & King, J. Evolution of gonadotropin-releasing hormone: multiple usage of a peptide. Physiology 3, 49-53 (1988)
27. Millar, R. P. et al. Plasticity in the structural and functional evolution of GnRH: a peptide for all seasons. In Proc. Thirteenth International Congress of Comparative Endocrinology (Eds Kawashima, S. & Kikuyama, S.) 15-27 (Monduzzi Editore, Bologna, 1997)
28. Okubo, K., Suetake, H., Usami, T. & Aida, K. Molecular cloning and tissue-specific expression of a gonadotropin-releasing hormone receptor in the Japanese eel. Gen. Comp. Endocrinol. 119, 181-192 (2000)
29. Okubo, K., Amano, M., Yoshiura, Y., Suetake, H. & Aida, K. A novel form of gonadotropin-releasing hormone in the medaka, Oryzias latipes. Biochem. Biophys. Res. Commun. 276, 298-303 (2000)
30. Sherwood, N. M. & Lovejoy, D. A. The origin of the mammalian form of GnRH in primitive fishes. Fish Physiol. Biochem. 7, 85-93 (1989)
31. Sherwood, N. M., Lovejoy, D. A. & Coe, I. R. Origin of mammalian gonadotropin-releasing hormones. Endocr. Rev. 14, 241-254 (1993)
32. Yoo, M. S. et al. Molecular cloning, distribution and pharmacological characterization of a novel gonadotropin-releasing hormone ([Trp8] GnRH) in frog brain. Mol. Cell. Endocrinol. 164, 197-204 (2000)
33. Roch, G. J., Busby, E. R. & Sherwood, N. M. Evolution of GnRH: diving deeper. Gen. Comp. Endocrinol. 171, 1-16 (2011)
34. Sherwood, N. The GnRH family of peptides. Trends Neurosci. 10, 129-132 (1987)
35. Flanagan, C. A. et al. Glutamate 301 of the mouse gonadotropin-releasing hormone receptor confers specificity for arginine 8 of mammalian gonadotropin-releasing hormone. J. Biol. Chem. 269, 22636-22641 (1994)
36. Barran, P. E. et al. Evolution of constrained gonadotropin-releasing hormone ligand conformation and receptor selectivity. J. Biol. Chem. 280, 38569-38575 (2005)
37. Pfleger, K. D., Bogerd, J. & Millar, R. P. Conformational constraint of mammalian, chicken, and salmon GnRHs, but not GnRH II, enhances binding at mammalian and nonmammalian receptors: evidence for preconfiguration of GnRH II. Mol. Endocrinol. 16, 2155-2162 (2002)
38. Karten, M. J. & Rivier, J. E. Gonadotropin-releasing hormone analog design. Structure-function studies toward the development of agonists and antagonists: rationale and perspective. Endocr. Rev. 7, 44-66 (1986)
39. Sealfon, S. C., Weinstein, H. & Millar, R. P. Molecular mechanisms of ligand interaction with the gonadotropin-releasing hormone receptor. Endocr. Rev. 18, 180-205 (1997)
40. Heitman, L. H. & Ijzerman, A. P. G protein-coupled receptors of the hypothalamic-pituitary-gonadal axis: a case for Gnrh, LH, FSH, and GPR54 receptor ligands. Med. Res. Rev. 28, 975-1011 (2008)
41. Betz, S. F., Reinhart, G. J., Lio, F. M., Chen, C. & Struthers, R. S. Overlapping, nonidentical binding sites of different classes of nonpeptide antagonists for the human gonadotropin-releasing hormone receptor. J. Med. Chem. 49, 637-647 (2006)
42. Cui, J. et al. Identification of Phe313 of the gonadotropin-releasing hormone (GnRH) receptor as a site critical for the binding of nonpeptide GnRH antagonists. Mol. Endocrinol. 14, 671-681 (2000)
43. Chen, C. et al. Discovery of sodium R-(+)-4-{2-[5-(2-fluoro-3- methoxyphenyl)-3-(2-fluoro-6-[trifluoromethyl]benzyl)-4 -methyl-2, 6-dioxo-3, 6-dihydro-2H-pyrimidin-1-yl]-1-phenylethylamino}butyrate (elagolix), a potent and orally available nonpeptide antagonist of the human gonadotropin-releasing hormone receptor. J. Med. Chem. 51, 7478-7485 (2008)
44. Miwa, K. et al. Discovery of 1-{4-[1-(2, 6-difluorobenzyl)-5- [(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2, 4-dioxo-1, 2, 3, 4-tetrahydrothieno[2, 3-d]pyrimidin-6-yl]phenyl}-3-methoxyurea (TAK-385) as a potent, orally active, non-peptide antagonist of the human gonadotropin- releasing hormone receptor. J. Med. Chem. 54, 4998-5012 (2011)
45. Struthers, R. S. et al. Suppression of gonadotropins and estradiol in premenopausal women by oral administration of the nonpeptide gonadotropin-releasing hormone antagonist elagolix. J. Clin. Endocrinol. Metab. 94, 545-551 (2009)
46. Finch, A. R., Sedgley, K. R., Caunt, C. J. & McArdle, C. A. Plasma membrane expression of GnRH receptors: regulation by antagonists in breast, prostate, and gonadotrope cell lines. J. Endocrinol. 196, 353-367 (2008)
47. Conn, P. M. & Ulloa-Aguirre, A. Pharmacological chaperones for misfolded gonadotropin-releasing hormone receptors. Adv. Pharmacol. 62, 109-141 (2011)
48. Conn, P. M. & Ulloa-Aguirre, A. Trafficking of G-protein-coupled receptors to the plasma membrane: insights for pharmacoperone drugs. Trends Endocrinol. Metab. 21, 190-197 (2010)
49. Tsutsumi, M. Cloning and functional expression of a mouse gonadotropin-releasing hormone receptor. Mol. Endocrinol. 6, 1163-1169 (1992)
50. Pawson, A. J. et al. Mammalian type I gonadotropin-releasing hormone receptors undergo slow, constitutive, agonist-independent internalization. Endocrinology 149, 1415-1422 (2008)
51. Lahlou, N. et al. Gonadotropin and alpha-subunit secretion during long term pituitary suppression by D-Trp6-luteinizing hormone-releasing hormone microcapsules as treatment of precocious puberty. J. Clin. Endocrinol. Metab. 65, 946-953 (1987)
52. Millar, R. P., Pawson, A. J., Morgan, K., Rissman, E. F. & Lu, Z. L. Diversity of actions of GnRHs mediated by ligand-induced selective signaling. Front. Neuroendocrinol. 29, 17-35 (2008)
53. Casper, R. F. Clinical uses of gonadotropin-releasing hormone analogues. CMAJ 144, 153-158 (1991)
54. Conn, P. M. & Crowley, W. F. Jr. Gonadotropin-releasing hormone and its analogues. N. Engl. J. Med. 324, 93-103 (1991)
55. Barbieri, R. L. Clinical applications of GnRH and its analogues Trends Endocrinol. Metab. 3, 30-34 (1992)
56. Moghissi, K. S. Clinical applications of gonadotropin-releasing hormones in reproductive disorders. Endocrinol. Metab. Clin. North Am. 21, 125-140 (1992)
57. Filicori, M. Gonadotrophin-releasing hormone agonists. A guide to use and selection. Drugs 48, 41-58 (1994)
58. Emons, G. & Schally, A. V. The use of luteinizing hormone releasing hormone agonists and antagonists in gynaecological cancers. Hum. Reprod. 9, 1364-1379 (1994)
59. Rivier, J. E. et al. New effective gonadotropin releasing hormone antagonists with minimal potency for histamine release in vitro. J. Med. Chem. 29, 1846-1851 (1986)
60. Schlegel, P. N. et al. Effective long-term androgen suppression in men with prostate cancer using a hydrogel implant with the GnRH agonist histrelin. Urology 58, 578-582 (2001)
61. Barbieri, R. L. Hormone treatment of endometriosis: the estrogen threshold hypothesis. Am. J. Obstet. Gynecol 166, 740-745 (1992)
62. Surrey, E. S. Add-back therapy and gonadotropin-releasing hormone agonists in the treatment of patients with endometriosis: can a consensus be reached? Add-Back Consensus Working Group. Fertil. Steril. 71, 420-424 (1999)
63. Franke, H. R., van de Weijer, P. H., Pennings, T. M. & van der Mooren, M. J. Gonadotropin-releasing hormone agonist plus "add-back" hormone replacement therapy for treatment of endometriosis: a prospective, randomized, placebo-controlled, double-blind trial. Fertil. Steril. 74, 534-539 (2000)
64. Ratcliffe, K. E., Fraser, H. M., Sellar, R., Rivier, J. & Millar, R. P. Bifunctional gonadotropin-releasing hormone antagonist-progesterone analogs with increased efficacy and duration of action. Endocrinology 147, 571-579 (2006)
65. Akaza, H. Future prospects for luteinizing hormone-releasing hormone analogues in prostate cancer treatment. Pharmacology 85, 110-120 (2010)
66. Porter, R. N., Smith, W., Craft, I. L., Abdulwahid, N. A. & Jacobs, H. S. Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins. Lancet 2, 1284-1285 (1984)
67. Kiesel, L. A., Rody, A., Greb, R. R. & Szilágyi, A. Clinical use of GnRH analogues. Clin. Endocrinol. 56, 677-687 (2002)
68. Franks, S. Polycystic ovary syndrome. N. Engl. J. Med. 333, 853-861 (1995)
69. Lethaby, A., Vollenhoven, B. & Sowter, M. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids. Cochrane Database of Systematic Reviews Issue 2. Art. No.: CD000547 doi:10.1002/14651858. CD000547 (2001)
70. Colacurci, N. et al. The use of GnRH agonists depot for the treatment of dysfunctional uterine bleeding. Acta Eur. Fertil. 22, 229-231 (1991)
71. Klijn, J. G. M. et al. Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: a randomized study. J. Natl Cancer Inst. 92, 903-911 (2000)
72. So, W.-K., Cheng, J.-C., Poon, S.-L. & Leung, P. C. K. Gonadotropin-releasing hormone and ovarian cancer: a functional and mechanistic overview. FEBS J. 275, 5496-5511 (2008)
73. Wang, P. H., Chao, H. T. & Lee, W. L. Use of a long-acting gonadotropin-releasing hormone agonist for treatment of steroid cell tumors of the ovary. Fertil. Steril. 69, 353-355 (1998)
74. Covens, A. et al. A phase II study of leuprolide in advanced/recurrent endometrial cancer. Gynecol. Oncol. 64, 126-129 (1997)
75. Dockray, G. J. The expanding family of -RFamide peptides and their effects on feeding behaviour. Exp. Physiol. 89, 229-235 (2004)
76. Ohtaki, T. et al. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature 411, 613-617 (2001)
77. Roseweir, A. K. & Millar, R. P. The role of kisspeptin in the control of gonadotrophin secretion. Hum. Reprod. Update 15, 203-212 (2009)
78. Kotani, M. et al. The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J. Biol. Chem. 276, 34631-34636 (2001)
79. Mikkelsen, J. D., Bentsen, A. H., Ansel, L., Simonneaux, V. & Juul, A. Comparison of the effects of peripherally administered kisspeptins. Regul. Pept. 152, 95-100 (2009)
80. Tovar, S. et al. Effects of single or repeated intravenous administration of kisspeptin upon dynamic LH secretion in conscious male rats. Endocrinology 147, 2696-2704 (2006)
81. Thompson, E. L. et al. Central and peripheral administration of kisspeptin-10 stimulates the hypothalamic-pituitary-gonadal axis. J. Neuroendocrinol. 16, 850-858 (2004)
82. Navarro, V. M. et al. Effects of KiSS-1 peptide, the natural ligand of GPR54, on follicle-stimulating hormone secretion in the rat. Endocrinology 146, 1689-1697 (2005)
83. Navarro, V. M. et al. Characterization of the potent luteinizing hormone-releasing activity of KiSS-1 peptide, the natural ligand of GPR54. Endocrinology 146, 156-163 (2005)
84. Plant, T. M., Ramaswamy, S. & Dipietro, M. J. Repetitive activation of hypothalamic G protein-coupled receptor 54 with intravenous pulses of kisspeptin in the juvenile monkey (Macaca mulatta) elicits a sustained train of gonadotropin-releasing hormone discharges. Endocrinology 147, 1007-1013 (2006)
85. Shahab, M. et al. Increased hypothalamic GPR54 signaling: a potential mechanism for initiation of puberty in primates. Proc. Natl Acad. Sci. USA 102, 2129-2134 (2005)
86. Irwig, M. S. et al. Kisspeptin activation of gonadotropin releasing hormone neurons and regulation of KiSS-1 mRNA in the male rat. Neuroendocrinology 80, 264-272 (2004)
87. Messager, S. et al. Kisspeptin directly stimulates gonadotropin-releasing hormone release via G protein-coupled receptor 54. Proc. Natl Acad. Sci. USA 102, 1761-1766 (2005)
88. Dhillo, W. S. et al. Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males. J. Clin. Endocrinol. Metab. 90, 6609-6615 (2005)
89. George, J. T., Millar, R. P. & Anderson, R. A. Hypothesis: kisspeptin mediates male hypogonadism in obesity and type 2 diabetes. Neuroendocrinology 91, 302-307 (2010)
90. George, J. T. et al. Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men. J. Clin. Endocrinol. Metab. 96, E1228-E1236 (2011)
91. Dhillo, W. S. et al. Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women. J. Clin. Endocrinol. Metab. 92, 3958-3966 (2007)
92. Estrada, K. M., Clay, C. M., Pompolo, S., Smith, J. T. & Clarke, I. J. Elevated KiSS-1 expression in the arcuate nucleus prior to the cyclic preovulatory gonadotrophin-releasing hormone/lutenising hormone surge in the ewe suggests a stimulatory role for kisspeptin in oestrogen-positive feedback. J. Neuroendocrinol. 18, 806-809 (2006)
93. Franceschini, I. et al. Kisspeptin immunoreactive cells of the ovine preoptic area and arcuate nucleus co-express estrogen receptor alpha. Neurosci. Lett. 401, 225-230 (2006)
94. Smith, J. T., Cunningham, M. J., Rissman, E. F., Clifton, D. K. & Steiner, R. A. Regulation of Kiss1 gene expression in the brain of the female mouse. Endocrinology 146, 3686-3692 (2005)
95. Smith, J. T. et al. Differential regulation of KiSS-1 mRNA expression by sex steroids in the brain of the male mouse. Endocrinology 146, 2976-2984 (2005)
96. Adachi, S. et al. Involvement of anteroventral periventricular metastin/kisspeptin neurons in estrogen positive feedback action on luteinizing hormone release in female rats. J. Reprod. Dev. 53, 367-378 (2007)
97. Clarkson, J. & Herbison, A. E. Postnatal development of kisspeptin neurons in mouse hypothalamus; sexual dimorphism and projections to gonadotropin-releasing hormone neurons. Endocrinology 147, 5817-5825 (2006)
98. Pompolo, S., Pereira, A., Estrada, K. M. & Clarke, I. J. Colocalization of kisspeptin and gonadotropin-releasing hormone in the ovine brain. Endocrinology 147, 804-810 (2006)
99. Ramaswamy, S., Guerriero, K. A., Gibbs, R. B. & Plant, T. M. Structural interactions between kisspeptin and GnRH neurons in the mediobasal hypothalamus of the male rhesus monkey (Macaca mulatta) as revealed by double immunofluorescence and confocal microscopy. Endocrinology 149, 4387-4395 (2008)
100. .Tena-Sempere, M. KiSS-1 and reproduction: focus on its role in the metabolic regulation of fertility. Neuroendocrinology 83, 275-281 (2006)
101. .Roa, J., Aguilar, E., Dieguez, C., Pinilla, L. & Tena-Sempere, M. New frontiers in kisspeptin/GPR54 physiology as fundamental gatekeepers of reproductive function. Front. Neuroendocrinol. 29, 48-69 (2008)
102. Smith, J. T., Acohido, B. V., Clifton, D. K. & Steiner, R. A. KiSS-1 neurones are direct targets for leptin in the ob/ob mouse. J. Neuroendocrinol. 18, 298-303 (2006)
103. Donato, J. Jr. et al. Leptin's effect on puberty in mice is relayed by the ventral premammillary nucleus and does not require signaling in Kiss1 neurons. J. Clin. Invest. 121, 355-368 (2011)
104. Castellano, J. M. et al. Alterations in hypothalamic KiSS-1 system in experimental diabetes: early changes and functional consequences. Endocrinology 150, 784-794 (2009)
105. Castellano, J. M. et al. Changes in hypothalamic KiSS-1 system and restoration of pubertal activation of the reproductive axis by kisspeptin in undernutrition. Endocrinology 146, 3917-3925 (2005)
106. Pinilla, L., Aguilar, E., Dieguez, C., Millar, R. P. & Tena-Sempere, M. Kisspeptins and reproduction: physiological roles and regulatory mechanisms. Physiol. Rev. 92, 1235-1316 (2012)
107. Oakley, A. E., Clifton, D. K. & Steiner, R. A. Kisspeptin signaling in the brain. Endocr. Rev. 30, 713-743 (2009)
108. Orsini, M. J. et al. Metastin (KiSS-1) mimetics identified from peptide structure-activity relationship-derived pharmacophores and directed small molecule database screening. J. Med. Chem. 50, 462-471 (2007)
109. Gutierrez-Pascual, E. et al. In vivo and in vitro structure-activity relationships and structural conformation of kisspeptin-10-related peptides. Mol. Pharmacol. 76, 58-67 (2009)
110. Roseweir, A. K. et al. Discovery of potent kisspeptin antagonists delineate physiological mechanisms of gonadotropin regulation. J. Neurosci. 29, 3920-3929 (2009)
111. Millar, R. P. et al. Kisspeptin antagonists: unraveling the role of kisspeptin in reproductive physiology. Brain Res. 1364, 81-89 (2010)
112. Asami, T. & Nishizawa, N. Metastin derivatives and use thereof. US Patent 7,960,348 B2 (2011)
113. Kitada, C., Asami, T. & Nishizawa, N. Metastin derivatives and use thereof. US Patent 7,625,869 (2009)
114. Matsui, H. et al. Chronic administration of the metastin/kisspeptin analog KISS1-305 or the investigational agent TAK-448 suppresses hypothalamic pituitary gonadal function and depletes plasma testosterone in adult male rats. Endocrinology 153, 5297-5308 (2012)
115. Liu, X. et al. Frequency-dependent recruitment of fast amino acid and slow neuropeptide neurotransmitter release controls gonadotropin-releasing hormone neuron excitability. J. Neurosci. 31, 2421-2430 (2011)
116. Kinoshita, M. et al. Involvement of central metastin in the regulation of preovulatory luteinizing hormone surge and estrous cyclicity in female rats. Endocrinology 146, 4431-4436 (2005)
117. Pineda, R. et al. Critical roles of kisspeptins in female puberty and preovulatory gonadotropin surges as revealed by a novel antagonist. Endocrinology 151, 722-730 (2010)
118. Kobayashi, T. et al. Synthesis and structure-activity relationships of 2-acylamino-4, 6-diphenylpyridine derivatives as novel antagonists of GPR54. Bioorg. Med. Chem. 18, 3841-3859 (2010)
119. Kobayashi, T. et al. 2-acylamino-4, 6-diphenylpyridine derivatives as novel GPR54 antagonists with good brain exposure and in vivo efficacy for plasma LH level in male rats. Bioorg. Med. Chem. 18, 5157-5171 (2010)
120. Guerriero, K. A., Keen, K. L., Millar, R. P. & Terasawa, E. Developmental changes in GnRH release in response to kisspeptin agonist and antagonist in female rhesus monkeys (Macaca mulatta): implication for the mechanism of puberty. Endocrinology 153, 825-836 (2012)
121. Li, X. F. et al. Kisspeptin signalling in the hypothalamic arcuate nucleus regulates GnRH pulse generator frequency in the rat. PLoS ONE 4, e8334 (2009)
122. Smith, J. T. et al. Kisspeptin is essential for the full preovulatory LH surge and stimulates GnRH release from the isolated ovine median eminence. Endocrinology 152, 1001-1012 (2011)
123. Jayasena, C. N. et al. Subcutaneous injection of kisspeptin-54 acutely stimulates gonadotropin secretion in women with hypothalamic amenorrhea, but chronic administration causes tachyphylaxis. J. Clin. Endocrinol. Metab. 94, 4315-4323 (2009)
124. George, J. T., Anderson, R. A. & Millar, R. P. Kisspeptin-10 stimulation of gonadotrophin secretion in women is modulated by sex steroid feedback. Hum. Reprod. 27, 3552-3559 (2012)
125. George, J. T., Veldhuis, J. D., Tena-Sempere, M., Millar, R. P. & Anderson, R. A. Exploring the pathophysiology of hypogonadism in men with type 2 diabetes: Kisspeptin-10 stimulates serum testosterone and LH secretion in men with type 2 diabetes and mild biochemical hypogonadism. Clin. Endocrinol. (Oxf.) 79, 100-104 (2013)
126. Durnerin, C. I. et al. Effects of recombinant LH treatment on folliculogenesis and responsiveness to FSH stimulation. Hum. Reprod. 23, 421-426 (2008)
127. Drakakis, P. et al. Early hCG addition to rFSH for ovarian stimulation in IVF provides better results and the cDNA copies of the hCG receptor may be an indicator of successful stimulation. Reprod. Biol. Endocrinol. 7, 110 (2009)
128. Kung, T. T. et al. Tachykinin NK3-receptor deficiency does not inhibit pulmonary eosinophilia in allergic mice. Pharmacol. Res. 50, 611-615 (2004)
129. Yang, J. J., Caligioni, C. S., Chan, Y. M. & Seminara, S. B. Uncovering novel reproductive defects in neurokinin B receptor null mice: closing the gap between mice and men. Endocrinology 153, 1498-1508 (2012)
130. Navarro, V. M. New insights into the control of pulsatile GnRH release: the role of Kiss1/neurokinin B neurons. Front. Endocrinol. 3, 48 (2012)
131. Ramaswamy, S., Seminara, S. B. & Plant, T. M. Evidence from the agonadal juvenile male rhesus monkey (Macaca mulatta) for the view that the action of neurokinin B to trigger gonadotropin-releasing hormone release is upstream from the kisspeptin receptor. Neuroendocrinology 94, 237-245 (2011)
132. Wakabayashi, Y. et al. Neurokinin B and dynorphin A in kisspeptin neurons of the arcuate nucleus participate in generation of periodic oscillation of neural activity driving pulsatile gonadotropin-releasing hormone secretion in the goat. J. Neurosci. 30, 3124-3132 (2010)
133. Billings, H. J. et al. Neurokinin B acts via the neurokinin-3 receptor in the retrochiasmatic area to stimulate luteinizing hormone secretion in sheep. Endocrinology 151, 3836-3846 (2010)
134. Dalkin, A. C., Haisenleder, D. J., Ortolano, G. A., Ellis, T. R. & Marshall, J. C. The frequency of gonadotropin-releasing-hormone stimulation differentially regulates gonadotropin subunit messenger ribonucleic acid expression. Endocrinology 125, 917-924 (1989)
135. Young, J. et al. Kisspeptin restores pulsatile LH secretion in patients with neurokinin B signaling deficiencies: physiological, pathophysiological and therapeutic implications. Neuroendocrinology 97, 193-202 (2013).
136. Lehman, M. N., Coolen, L. M. & Goodman, R. L. Minireview: kisspeptin/neurokinin B/dynorphin (KNDy) cells of the arcuate nucleus: a central node in the control of gonadotropin-releasing hormone secretion. Endocrinology 151, 3479-3489 (2010)
137. Goodman, R. L. et al. Kisspeptin neurons in the arcuate nucleus of the ewe express both dynorphin A and neurokinin B. Endocrinology 148, 5752-5760 (2007)
138. Navarro, V. M. et al. Regulation of NKB pathways and their roles in the control of Kiss1 neurons in the arcuate nucleus of the male mouse. Endocrinology 152, 4265-4275 (2011)
139. Amstalden, M. et al. Neurokinin 3 receptor immunoreactivity in the septal region, preoptic area and hypothalamus of the female sheep: colocalisation in neurokinin B cells of the arcuate nucleus but not in gonadotrophin-releasing hormone neurones. J. Neuroendocrinol. 22, 1-12 (2010)
140. Kangawa, K., Minamino, N., Fukuda, A. & Matsuo, H. Neuromedin K: a novel mammalian tachykinin identified in porcine spinal cord. Biochem. Biophys. Res. Commun. 114, 533-540 (1983)
141. Laufer, R. et al. Neurokinin B is a preferred agonist for a neuronal substance P receptor and its action is antagonized by enkephalin. Proc. Natl Acad. Sci. USA 82, 7444-7448 (1985)
142. Buck, S. H., Burcher, E., Shults, C. W., Lovenberg, W. & O'Donohue, T. L. Novel pharmacology of substance K-binding sites: a third type of tachykinin receptor. Science 226, 987-989 (1984)
143. Torrens, Y. et al. Neuromedin K, a tool to further distinguish two central tachykinin binding sites. Eur. J. Pharmacol. 102, 381-382 (1984)
144. Buell, G. et al. Molecular characterisation, expression and localisation of human neurokinin-3 receptor. FEBS Lett. 299, 90-95 (1992)
145. Wormser, U. et al. Highly selective agonists for substance P receptor subtypes. EMBO J. 5, 2805-2808 (1986)
146. Laufer, R., Gilon, C., Chorev, M. & Selinger, Z. Characterization of a neurokinin B receptor site in rat brain using a highly selective radioligand. J. Biol. Chem. 261, 10257-10263 (1986)
147. Drapeau, G. et al. Selective agonists for substance P and neurokinin receptors. Neuropeptides 10, 43-54 (1987)
148. Lavielle, S. et al. Selective agonists of tachykinin binding sites. Fundam. Clin. Pharmacol. 4, 257-268 (1990)
149. Boden, P. et al. Use of a dipeptide chemical library in the development of non-peptide tachykinin NK3 receptor selective antagonists. J. Med. Chem. 39, 1664-1675 (1996)
150. Emonds-Alt, X. et al. SR 142801, the first potent non-peptide antagonist of the tachykinin NK3 receptor. Life Sci. 56, PL27-PL32 (1995)
151. Oury-Donat, F. et al. Functional characterization of the nonpeptide neurokinin3 (NK3) receptor antagonist, SR142801 on the human NK3 receptor expressed in Chinese hamster ovary cells. J. Pharmacol. Exp. Ther. 274, 148-154 (1995)
152. Chung, F. Z. et al. Two classes of structurally different antagonists display similar species preference for the human tachykinin neurokinin3 receptor. Mol. Pharmacol. 48, 711-716 (1995)
153. Nguyen-Le, X. K. et al. Pharmacological characterization of SR 142801: a new non-peptide antagonist of the neurokinin NK-3 receptor. Pharmacology 52, 283-291 (1996)
154. Emonds-Alt, X. et al. Biochemical and pharmacological activities of SSR 146977, a new potent nonpeptide tachykinin NK3 receptor antagonist. Can. J. Physiol. Pharmacol. 80, 482-488 (2002)
155. Harrison, T. et al. High affinity, selective neurokinin 2 and neurokinin 3 receptor antagonists from a common structural template. Bioorg. Med. Chem. Lett. 8, 1343-1348 (1998)
156. Giardina, G. A. et al. 2-Phenyl-4-quinolinecarboxamides: a novel class of potent and selective non-peptide competitive antagonists for the human neurokinin-3 receptor. J. Med. Chem. 39, 2281-2284 (1996)
157. Giardina, G. A. et al. Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 1. Identification of the 4-quinolinecarboxamide framework. J. Med. Chem. 40, 1794-1807 (1997)
158. Giardina, G. A. et al. Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 2. Identification of (S)-N-(1-phenylpropyl)-3-hydroxy-2-phenylquinoline-4-carboxamide (SB 223412). J. Med. Chem 42, 1053-1065 (1999)
159. Sarau, H. M. et al. Nonpeptide tachykinin receptor antagonists: I. Pharmacological and pharmacokinetic characterization of SB 223412, a novel, potent and selective neurokinin-3 receptor antagonist. J. Pharmacol. Exp. Ther. 281, 1303-1311 (1997)
160. Sarau, H. M. et al. Nonpeptide tachykinin receptor antagonists. II. Pharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potent and selective NK-3 receptor antagonist. J. Pharmacol. Exp. Ther. 295, 373-381 (2000)
161. Smith, P. W. et al. New quinoline NK3 receptor antagonists with CNS activity. Bioorg. Med. Chem. Lett. 19, 837-840 (2009)
162. Hay, D. W. et al. Nonpeptide tachykinin receptor antagonists. III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyper-reactivity in guinea pigs. J. Pharmacol. Exp. Ther. 300, 314-323 (2002)
163. Li, Y. et al. In vitro assessment of metabolic drug-drug interaction potential of AZD2624, neurokinin-3 receptor antagonist, through cytochrome P(450) enzyme identification, inhibition, and induction studies. Xenobiotica 40, 721-729 (2010)
164. Elliott, J. M. et al. N',2-diphenylquinoline-4-carbohydrazide based NK3 receptor antagonists II. Bioorg. Med. Chem. Lett. 16, 5752-5756 (2006)
165. Sarau, H. M. et al. Molecular and pharmacological characterization of the murine tachykinin NK(3) receptor. Eur. J. Pharmacol. 413, 143-150 (2001)
166. Griebel, G. & Beeske, S. Is there still a future for neurokinin 3 receptor antagonists as potential drugs for the treatment of psychiatric diseases? Pharmacol. Ther. 133, 116-123 (2012)
167. Gordon, C. M. Clinical practice. Functional hypothalamic amenorrhea. N. Engl. J. Med. 363, 365-371 (2010).
168. Blank, S. K., McCartney, C. R. & Marshall, J. C. The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome. Hum. Reprod. Update 12, 351-361 (2006)
169. Seminara, S. B., Dipietro, M. J., Ramaswamy, S., Crowley, W. F. Jr & Plant, T. M. Continuous human metastin 45-54 infusion desensitizes G protein-coupled receptor 54-induced gonadotropin-releasing hormone release monitored indirectly in the juvenile male Rhesus monkey (Macaca mulatta): a finding with therapeutic implications. Endocrinology 147, 2122-2126 (2006)
170. Ramaswamy, S. et al. Effect of continuous intravenous administration of human metastin 45-54 on the neuroendocrine activity of the hypothalamic- pituitary-testicular axis in the adult male rhesus monkey (Macaca mulatta). Endocrinology 148, 3364-3370 (2007).